StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/3016% above fair value
$2.95−0.03 (-1.01%)

Close on Nov 20, 2026Market cap $69.20MP/E –Yield –

Coya Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Coya Therapeutics

Coya Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Coya Therapeutics figures

See a number that looks wrong?